GREEN LIFESCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,976 KRW | 0.00% |
|
-1.20% | -11.19% |
| 07/05 | Green Lifescience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 06/03 | Green Lifescience Co., Ltd.'s Equity Buyback Plan Extended till September 6, 2024. | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 63,750 | 92,550 | 1,83,750 | 1,51,500 | 88,950 | 44,500 |
| Enterprise Value (EV) 1 | 48,313 | 77,542 | 1,74,796 | 1,42,892 | 78,626 | 34,980 |
| P/E ratio | -44.1 x | 77.4 x | -173 x | -48.3 x | -25.2 x | -2.72 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.95 x | 2.46 x | 7.48 x | 5.98 x | 2.44 x | 1.99 x |
| EV / Revenue | 1.48 x | 2.06 x | 7.12 x | 5.64 x | 2.15 x | 1.56 x |
| EV / EBITDA | 31 x | 19.5 x | 230 x | -68.6 x | -66.1 x | -16.1 x |
| EV / FCF | -26.8 x | -405 x | -262 x | -82 x | -15.9 x | 43.1 x |
| FCF Yield | -3.73% | -0.25% | -0.38% | -1.22% | -6.27% | 2.32% |
| Price to Book | 1.08 x | 1.53 x | 3.09 x | 2.69 x | 1.69 x | 1.23 x |
| Nbr of stocks (in thousands) | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 |
| Reference price 2 | 3,188 | 4,628 | 9,188 | 7,575 | 4,448 | 2,225 |
| Announcement Date | 01/03/19 | 29/02/20 | 01/03/21 | 01/03/22 | 01/03/23 | 29/02/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 32,754 | 37,618 | 24,561 | 25,338 | 36,505 | 22,369 |
| EBITDA 1 | 1,558 | 3,971 | 758.6 | -2,083 | -1,189 | -2,167 |
| EBIT 1 | -1,952 | 591.1 | -1,909 | -4,648 | -3,958 | -4,643 |
| Operating Margin | -5.96% | 1.57% | -7.77% | -18.35% | -10.84% | -20.76% |
| Earnings before Tax (EBT) 1 | -2,186 | 1,340 | -871.4 | -3,418 | -2,860 | -16,358 |
| Net income 1 | -1,445 | 1,196 | -1,059 | -3,136 | -3,526 | -16,358 |
| Net margin | -4.41% | 3.18% | -4.31% | -12.38% | -9.66% | -73.13% |
| EPS 2 | -72.26 | 59.79 | -52.97 | -156.8 | -176.3 | -819.5 |
| Free Cash Flow 1 | -1,802 | -191.3 | -666 | -1,743 | -4,933 | 812.2 |
| FCF margin | -5.5% | -0.51% | -2.71% | -6.88% | -13.51% | 3.63% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 01/03/19 | 29/02/20 | 01/03/21 | 01/03/22 | 01/03/23 | 29/02/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 15,437 | 15,008 | 8,954 | 8,608 | 10,324 | 9,520 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -1,802 | -191 | -666 | -1,743 | -4,933 | 812 |
| ROE (net income / shareholders' equity) | -2.38% | 2% | -1.77% | -5.42% | -6.47% | -36.9% |
| ROA (Net income/ Total Assets) | -1.71% | 0.52% | -1.67% | -4.07% | -3.68% | -5.46% |
| Assets 1 | 84,307 | 2,28,627 | 63,378 | 77,084 | 95,780 | 2,99,494 |
| Book Value Per Share 2 | 2,956 | 3,018 | 2,969 | 2,815 | 2,632 | 1,813 |
| Cash Flow per Share 2 | 26.20 | 376.0 | 120.0 | 169.0 | 141.0 | 320.0 |
| Capex 1 | 7,488 | 3,600 | 2,667 | 3,444 | 1,478 | 496 |
| Capex / Sales | 22.86% | 9.57% | 10.86% | 13.59% | 4.05% | 2.22% |
| Announcement Date | 01/03/19 | 29/02/20 | 01/03/21 | 01/03/22 | 01/03/23 | 29/02/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -11.19% | 2.84Cr | |
| +20.78% | 4.33TCr | |
| +27.64% | 2.24TCr | |
| +19.25% | 1.55TCr | |
| +18.68% | 1.45TCr | |
| +54.64% | 1.29TCr | |
| -0.05% | 678.76Cr | |
| -11.39% | 655.78Cr | |
| +18.33% | 587.1Cr | |
| -8.87% | 572.55Cr |
- Stock Market
- Equities
- A114450 Stock
- Financials Green Lifescience Co., Ltd.
